%0 Journal Article
%T In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells
%A Radhakrishnan Vishnubalaji
%A Muthurangan Manikandan
%A May Al-Nbaheen
%A Balamuthu Kadalmani
%A Abdullah Aldahmash
%A Nehad M Alajez
%J BMC Developmental Biology
%D 2012
%I BioMed Central
%R 10.1186/1471-213x-12-7
%X Concordant with previous studies, both MSCs and SSCs showed similar morphology, surface protein expression, and were able to differentiate into osteoblasts and adipocytes. Using an endothelial induction culture system combined with an in vitro matrigel angiogenesis assay, hNFSSCs and hADSSCs exhibited the highest tube-forming capability, which was similar to those formed by human umbilical vein endothelial cells (HUVEC), with hNFSSCs forming the most tightly packed, longest, and largest diameter tubules among the three cell types. CD146 was highly expressed on hNFSSCs and HUVEC followed by hADSSCs, and hMSC-TERT, while its expression was almost absent on hADMSCs. Similarly, higher vascular density (based on the expression of CD31, CD34, vWF, CD146 and SMA) was observed in neonatal skin, followed by adult dermal skin and adipose tissue. Thus, our preliminary data indicated a plausible relationship between vascular densities, and the expression of CD146 on multipotent cells derived from those tissues.Our data is the first to demonstrate that human dermal skin stromal cells can be differentiated into endothelial lineage. Hence, SSCs represents a novel source of stem/stromal cells for tissue regeneration and the vascularization of engineered tissues. Moreover, the CD146 investigations suggested that the microenvironmental niche might contribute to direct stromal cells multipotency toward certain lineages, which warrants further investigation.There is growing need for novel technologies to restore, maintain, and enhance organ function. Since the 90s, stem cells have emerged as a new venue for regenerative medicine and tissue engineering. Human embryonic stem (ES) cells, induced pluripotent stem (iPS) cells and mesenchymal stem cells (MSCs), all has emerged as potential source for regenerative medicine and tissue engineering applications [1]. Among those, MSCs appear to have several advantages including the possibility of using autologous cells and the excellent safety re
%U http://www.biomedcentral.com/1471-213X/12/7